Caitlin E Martin
Overview
Explore the profile of Caitlin E Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu K, Bello J, Buss J, Jones H, Bierut L, Stwalley D, et al.
Addict Sci Clin Pract
. 2025 Mar;
20(1):24.
PMID: 40065369
No abstract available.
2.
Stylli E, Martin C, Hong C, McLaughlin H, Janke M, Shah D, et al.
Fertil Steril
. 2025 Feb;
PMID: 39988130
No abstract available.
3.
Xu K, Jones H, Martin C, Smid M, Tiako M, Terplan M, et al.
J Addict Med
. 2025 Feb;
PMID: 39960779
Background: Substance use is a leading cause of pregnancy-associated death in the US. It is not known if the amount of perinatal content at national addiction science conferences reflects the...
4.
Martin C, Bjork J, Keyser-Marcus L, Sabo R, Pignatello T, Simmons K, et al.
Drug Alcohol Depend Rep
. 2025 Jan;
14:100304.
PMID: 39807348
Background: Evidence supports the common incidence of sleep disturbance in opioid use disorder (OUD) as a potential marker of disrupted orexin system functioning. This study evaluated the initial safety and...
5.
Xu K, Bello J, Buss J, Jones H, Bierut L, Stwalley D, et al.
Addict Sci Clin Pract
. 2025 Jan;
20(1):1.
PMID: 39762993
Background: The postpartum period provides an opportunity for birthing people with opioid use disorder (OUD) to consider their future reproductive health goals. However, the relationship between the use of medication...
6.
Xu K, Berkel T, Martin C, Jones H, Carter E, Kelly J, et al.
Nat Ment Health
. 2024 Dec;
2(7):801-808.
PMID: 39726823
While attention deficit hyperactivity disorder is common among people with addiction, the risks and benefits of attention deficit hyperactivity disorder medication in pregnant people with opioid use disorder are poorly...
7.
Parlier-Ahmad A, Ochalek T, Bean M, Wolver S, Carbone S, Islam L, et al.
Subst Use Addctn J
. 2024 Dec;
:29767342241303220.
PMID: 39676245
Introduction: Medication for opioid use disorder (MOUD) is the most efficacious treatment for opioid use disorder (OUD). MOUD uptake and continuation may be impacted by health concerns, including weight gain,...
8.
Jacobs J, Martin C, Fuemmeler B, Chen S
J Sleep Res
. 2024 Sep;
:e14331.
PMID: 39289841
Sleep is a complex biological process regulated by networks of neurons and environmental factors. As one falls asleep, neurotransmitters from sleep-wake regulating neurones work in synergy to control the switching...
9.
Humphries L, Applebaum J, Mainigi M, Martin C, Shah D
Fertil Steril
. 2024 Aug;
123(2):333-341.
PMID: 39187046
Objective: To identify independent predictors of a successful match to reproductive endocrinology and infertility (REI) fellowships, and to develop and internally validate a prediction model for REI match results. Design:...
10.
Stadtler H, Turkson S, Eglovitch M, Svikis D, Neigh G, Martin C
Arch Womens Ment Health
. 2024 Jul;
PMID: 39085616
This study aimed to explore the association between the degree of PTSD symptomatology and severity of insomnia symptoms in a clinical sample of women receiving buprenorphine for OUD. PTSD symptomatology...